Training Solutions Blog

Specifically curated for sales trainers in the pharmaceutical, biotech, and medical device industries

The average investment for a first indication launch was $13 million, with an average maximum spend of $20 million across the 12 pharma companies surveyed, which included Pfizer, Amgen, Bayer, Novartis and Eli Lilly.

Best Practices / Beth Snyder Bulik

© 2019 CLD, Inc. All Rights Reserved.